Detection and Characterization of Circulating Tumor Cells in Patients with Merkel Cell Carcinoma

Riethdorf S, Hildebrandt L, Heinzerling L, Heitzer E, Fischer N, Bergmann S, Mauermann O, Waldispuehl-Geigl J, Coith C, Schoen G, Peine S, Schuler G, Speicher MR, Moll I, Pantel K (2019)

Publication Type: Journal article

Publication year: 2019

Journal

Clinical Chemistry American Association for Clinical Chemistry

Book Volume: 65

Pages Range: 462-472

Journal Issue: 3

DOI: 10.1373/clinchem.2018.297028

Abstract

BACKGROUND: Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer with increasing incidence and high mortality rates. MCC has recently become the subject of immune checkpoint therapy, but reliable biomarkers for estimating prognosis, risk stratification, and prediction of response are missing.

Authors with CRIS profile

Lucie Heinzerling Department of Dermatology Gerold Schuler Lehrstuhl für Haut- und Geschlechtskrankheiten

Involved external institutions

Universitätsklinikum Hamburg-Eppendorf (UKE) DE Germany (DE) Karl-Franzens-Universität Graz AT Austria (AT)

How to cite

APA:

Riethdorf, S., Hildebrandt, L., Heinzerling, L., Heitzer, E., Fischer, N., Bergmann, S.,... Pantel, K. (2019). Detection and Characterization of Circulating Tumor Cells in Patients with Merkel Cell Carcinoma. Clinical Chemistry, 65(3), 462-472. https://doi.org/10.1373/clinchem.2018.297028

MLA:

Riethdorf, Sabine, et al. "Detection and Characterization of Circulating Tumor Cells in Patients with Merkel Cell Carcinoma." Clinical Chemistry 65.3 (2019): 462-472.

BibTeX: Download